Ibex Wealth Advisors Bristol Myers Squibb CO Transaction History

Ibex Wealth Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 22, 2022	SELL	$53.63 - $62.52 $5,148 - $6,001	-96 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5,680 - $6,653	96 New	96 $6,000
Q2 2021 Aug 20, 2021	SELL	$61.91 - $67.42 $5.57 Million - $6.07 Million	-89,983 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $130,666 - $146,961	-2,202 Reduced 2.39%	89,983 $5.68 Million
Q4 2020 Jan 22, 2021	BUY	$57.74 - $65.43 $36,376 - $41,220	630 Added 0.69%	92,185 $5.72 Million
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $351,356 - $389,349	6,118 Added 7.16%	91,555 $5.52 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $248,389 - $290,391	-4,531 Reduced 5.04%	85,437 $5.02 Million
Q1 2020 May 05, 2020	BUY	$46.4 - $67.43 $1.21 Million - $1.76 Million	26,040 Added 40.73%	89,968 $5.01 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $3.15 Million - $4.1 Million	63,928 New	63,928 $4.1 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Ibex Wealth Advisors with notifications on news.